BioCentury
ARTICLE | Company News

Management tracks: Hamburg joins Alnylam board

October 10, 2018 7:39 PM UTC

RNAi therapeutics company Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) appointed Margaret Hamburg to its board, effective Jan. 10, 2019. Hamburg is president-elect of the American Association for the Advancement of Science (AAAS), foreign secretary of the National Academy of Medicine and was FDA commissioner from 2009 to 2015.

Last month Hamburg co-authored an editorial in Science calling for systemic changes in the scientific community that address sexual and gender-based harassment. The editorial cited a June report from the National Academies of Sciences, Engineering, and Medicine that found more than half of women faculty or staff and 20-50% of women students in academic science, engineering or medicine have encountered or experienced sexual harassment. AAAS itself is introducing a fellow revocation policy that defines sexual harassment as a breach of professional ethics, which goes into effect Oct. 15 (see "Ex-FDA Chief Hamburg Says AAAS Will Take on Harassment")...

BCIQ Company Profiles

Alnylam Pharmaceuticals Inc.